BCA-1/CXCL13, Human
- 产品详情
- 实验流程
Primary Accession | O43927 |
---|---|
Sequence | Val23-Pro109 (accession number: O43927) , expressed with N-terminal His-tag. |
Purity | > 95% as analyzed by SDS-PAGE and HPLC. |
Endotoxin Level | < 0.2 EU/ µg, determined by LAL method. |
Gene ID | 10563 |
---|---|
Other Names | C-X-C motif chemokine 13, Angie, B cell-attracting chemokine 1, BCA-1, B lymphocyte chemoattractant, CXC chemokine BLC, Small-inducible cytokine B13, CXCL13, BCA1, BLC, SCYB13 |
Target Background | B cell-attracting chemokine 1 (BCA-1)/CXCL13, Human |
Name | CXCL13 |
---|---|
Synonyms | BCA1, BLC, SCYB13 |
Function | Chemotactic for B-lymphocytes but not for T-lymphocytes, monocytes and neutrophils. Does not induce calcium release in B- lymphocytes. Binds to BLR1/CXCR5. |
Cellular Location | Secreted. |
Tissue Location | Highest levels in liver, followed by spleen, lymph node, appendix and stomach. Low levels in salivary gland, mammary gland and fetal spleen |
Research Areas
For Research Use Only. Not For Use In Diagnostic Procedures.
Application Protocols
Provided below are standard protocols that you may find useful for product applications.

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。
如有疑问,联系:0512-88856768 tech-china@abcepta.com.